These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer. Nieminen P, Vuorma S, Viikki M, Hakama M, Anttila A. BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934 [Abstract] [Full Text] [Related]
5. Cervical specimens collected in liquid buffer are suitable for both cytologic screening and ancillary human papillomavirus testing. Sherman ME, Schiffman MH, Lorincz AT, Herrero R, Hutchinson ML, Bratti C, Zahniser D, Morales J, Hildesheim A, Helgesen K, Kelly D, Alfaro M, Mena F, Balmaceda I, Mango L, Greenberg M. Cancer; 1997 Apr 25; 81(2):89-97. PubMed ID: 9126136 [Abstract] [Full Text] [Related]
6. Colposcopic and histologic findings in women with a cytologic diagnosis of atypical squamous cells of undetermined significance. Yarandi F, Izadi Mood N, Mirashrafi F, Eftekhar Z. Aust N Z J Obstet Gynaecol; 2004 Dec 25; 44(6):514-6. PubMed ID: 15598287 [Abstract] [Full Text] [Related]
8. Cost-effectiveness analysis based on the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion Triage Study (ALTS). Kulasingam SL, Kim JJ, Lawrence WF, Mandelblatt JS, Myers ER, Schiffman M, Solomon D, Goldie SJ, ALTS Group. J Natl Cancer Inst; 2006 Jan 18; 98(2):92-100. PubMed ID: 16418511 [Abstract] [Full Text] [Related]
9. Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions. Arbyn M, Roelens J, Simoens C, Buntinx F, Paraskevaidis E, Martin-Hirsch PP, Prendiville WJ. Cochrane Database Syst Rev; 2013 Mar 28; 2013(3):CD008054. PubMed ID: 23543559 [Abstract] [Full Text] [Related]
10. The colposcopic impression. Is it influenced by the colposcopist's knowledge of the findings on the referral Papanicolaou smear? Pretorius RG, Belinson JL, Zhang WH, Burchette RJ, Elson P, Qiao YL. J Reprod Med; 2001 Aug 28; 46(8):724-8. PubMed ID: 11547646 [Abstract] [Full Text] [Related]
11. Clinical Significance of a cervical cytologic diagnosis of atypical squamous cells of undetermined significance. Favoring a reactive process or low grade squamous intraepithelial lesion. Gonzalez D, Hernandez E, Anderson L, Heller P, Atkinson BF. J Reprod Med; 1996 Oct 28; 41(10):719-23. PubMed ID: 9026557 [Abstract] [Full Text] [Related]
12. Cervical intraepithelial neoplasia in adolescent women: incidence and treatment outcomes. Case AS, Rocconi RP, Straughn JM, Wang W, Roark K, Waltman EE, Huh WK. Obstet Gynecol; 2006 Dec 28; 108(6):1369-74. PubMed ID: 17138768 [Abstract] [Full Text] [Related]
13. High-risk human papillomavirus detection in women with low-grade squamous intraepithelial lesions or higher-grade cytology using the Cervista HPV HR test. Gold MA, Thomas MA, Huh WK, Sarto GE, Day SP. J Low Genit Tract Dis; 2013 Jan 28; 17(1):51-7. PubMed ID: 22885641 [Abstract] [Full Text] [Related]
14. Triage of women with ASCUS and LSIL cytology: use of qualitative assessment of p16INK4a positive cells to identify patients with high-grade cervical intraepithelial neoplasia. Wentzensen N, Bergeron C, Cas F, Vinokurova S, von Knebel Doeberitz M. Cancer; 2007 Feb 25; 111(1):58-66. PubMed ID: 17186505 [Abstract] [Full Text] [Related]
15. European guidelines for quality assurance in cervical cancer screening: recommendations for clinical management of abnormal cervical cytology, part 1. Jordan J, Arbyn M, Martin-Hirsch P, Schenck U, Baldauf JJ, Da Silva D, Anttila A, Nieminen P, Prendiville W. Cytopathology; 2008 Dec 25; 19(6):342-54. PubMed ID: 19040546 [Abstract] [Full Text] [Related]
16. An evaluation of human papillomavirus testing as part of referral to colposcopy clinics. Cox JT, Schiffman MH, Winzelberg AJ, Patterson JM. Obstet Gynecol; 1992 Sep 25; 80(3 Pt 1):389-95. PubMed ID: 1323087 [Abstract] [Full Text] [Related]
17. HPV genotyping for triage of women with abnormal cervical cancer screening results: a multicenter prospective study. Nakamura Y, Matsumoto K, Satoh T, Nishide K, Nozue A, Shimabukuro K, Endo S, Nagai K, Oki A, Ochi H, Morishita Y, Noguchi M, Yoshikawa H. Int J Clin Oncol; 2015 Oct 25; 20(5):974-81. PubMed ID: 25652908 [Abstract] [Full Text] [Related]
18. Verrucous carcinoma of the cervix: detection of carcinogenetic human papillomavirus types and their role during follow-up. Frega A, Lukic A, Nobili F, Palazzo A, Iacovelli R, French D, Moscarini M. Anticancer Res; 2007 Oct 25; 27(6C):4491-4. PubMed ID: 18214065 [Abstract] [Full Text] [Related]
19. Atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion: diagnostic performance, human papillomavirus testing, and follow-up results. Srodon M, Parry Dilworth H, Ronnett BM. Cancer; 2006 Feb 25; 108(1):32-8. PubMed ID: 16136595 [Abstract] [Full Text] [Related]
20. The effectiveness of HPV16 and HPV18 genotyping and cytology with different thresholds for the triage of human papillomavirus-based screening on self-collected samples. Song F, Du H, Wang C, Huang X, Wu R, CHIMUST team. PLoS One; 2020 Feb 25; 15(6):e0234518. PubMed ID: 32525936 [Abstract] [Full Text] [Related] Page: [Next] [New Search]